Humoral Immunity After COVID-19 Vaccination in Chronic Lymphocytic Leukemia and Other Indolent Lymphomas: A Single-Center Observational Study.

Peter G DoukasFrederique St PierreReem KarmaliXinlei MiJennifer BoyerMariana NievesMichael G IsonJane N WinterLeo I GordonShuo Ma

Published in: The oncologist (2023)

Antibody response is lower in patients with indolent lymphomas compared to the general population. Lower Ab seropositivity was found in patients with a history of anti-leukemic agent therapy or those immunized with Pfizer vaccine. This data suggests that Moderna vaccination may confer a greater degree of immunity against SARS-CoV-2 in patients with indolent lymphomas.

Keyphrases

sars cov
chronic lymphocytic leukemia
hodgkin lymphoma
respiratory syndrome coronavirus
coronavirus disease
immune response
acute myeloid leukemia
electronic health record
big data